REHOVOT, Israel and NORTH BRUNSWICK, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Rosetta Genomics , today announced it will release third quarter financial results on November 8, 2007, before the U.S. markets open. Rosetta Genomics will host a conference call with a simultaneous webcast to discuss these results at 8:30 a.m. ET on November 8.
To access the live conference call, U.S. and Canadian participants may dial 1-866-966-5335; international participants may dial +44-20-3023-4460. To access the 24-hour audio replay, U.S. and Canadian participants may dial 1-866-583-1035; international participants may dial 44-20-8196-1996. The access code for the replay is 181543#.
The replay will be available until November 15, 2007. This conference call will also be webcasted live and archived on Rosetta Genomics’ website until November 22, 2007, at www.rosettagenomics.com.
About Rosetta Genomics
Rosetta Genomics is a leader in the field of microRNA. Founded in 2000, the Company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The Company’s primary focus is in the development of microRNA-based products to diagnose and treat different forms of cancer and infectious diseases. For more information, please visit www.rosettagenomics.com.
CONTACT: Media: Alan Zachary, +1-312-944-6784, media@rosettagenomics.com,
or Investors: Juliane Snowden, +1-212-213-0006,
investors@rosettagenomics.com, both of Rosetta Genomics
Web site: http://www.rosettagenomics.com/
